These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 26100152)
1. Immunotherapy with mutated onchocystatin fails to enhance the efficacy of a sub-lethal oxytetracycline regimen against Onchocerca ochengi. Bah GS; Tanya VN; Makepeace BL Vet Parasitol; 2015 Aug; 212(1-2):25-34. PubMed ID: 26100152 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of three-week oxytetracycline or rifampin monotherapy compared with a combination regimen against the filarial nematode Onchocerca ochengi. Bah GS; Ward EL; Srivastava A; Trees AJ; Tanya VN; Makepeace BL Antimicrob Agents Chemother; 2014; 58(2):801-10. PubMed ID: 24247133 [TBL] [Abstract][Full Text] [Related]
3. Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship. Langworthy NG; Renz A; Mackenstedt U; Henkle-Dührsen K; de Bronsvoort MB; Tanya VN; Donnelly MJ; Trees AJ Proc Biol Sci; 2000 Jun; 267(1448):1063-9. PubMed ID: 10885510 [TBL] [Abstract][Full Text] [Related]
4. Eosinophils contribute to killing of adult Onchocerca ochengi within onchocercomata following elimination of Wolbachia. Nfon CK; Makepeace BL; Njongmeta LM; Tanya VN; Bain O; Trees AJ Microbes Infect; 2006 Oct; 8(12-13):2698-705. PubMed ID: 16962357 [TBL] [Abstract][Full Text] [Related]
5. A worm's best friend: recruitment of neutrophils by Wolbachia confounds eosinophil degranulation against the filarial nematode Onchocerca ochengi. Hansen RD; Trees AJ; Bah GS; Hetzel U; Martin C; Bain O; Tanya VN; Makepeace BL Proc Biol Sci; 2011 Aug; 278(1716):2293-302. PubMed ID: 21177682 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). Gilbert J; Nfon CK; Makepeace BL; Njongmeta LM; Hastings IM; Pfarr KM; Renz A; Tanya VN; Trees AJ J Infect Dis; 2005 Oct; 192(8):1483-93. PubMed ID: 16170768 [TBL] [Abstract][Full Text] [Related]
7. Lack of resistance after re-exposure of cattle cured of Onchocerca ochengi infection with oxytetracycline. Nfon CK; Makepeace BL; Njongmeta LM; Tanya VN; Trees AJ Am J Trop Med Hyg; 2007 Jan; 76(1):67-72. PubMed ID: 17255232 [TBL] [Abstract][Full Text] [Related]
9. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments. Trees AJ; Graham SP; Renz A; Bianco AE; Tanya V Parasitology; 2000; 120 Suppl():S133-42. PubMed ID: 10874716 [TBL] [Abstract][Full Text] [Related]
10. Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi. Tchakouté VL; Bronsvoort M; Tanya V; Renz A; Trees AJ Parasitology; 1999 Feb; 118 ( Pt 2)():195-9. PubMed ID: 10028534 [TBL] [Abstract][Full Text] [Related]
11. Onchocerca ochengi male worms implanted in SCID mice and Gerbil: Relationship between microfilaridermia status of cows, nodular worm viability and fertility and worm survival in the rodents. Akumtoh DN; Njouendou AJ; Metuge HM; Sjoberg HT; Pionnier NP; Chunda VC; Gandjui NVT; Ndzeshang LB; Fombad FF; Abong RA; Enyong PA; Fru-Cho J; Esum ME; Ritter M; Taylor MJ; Turner JD; Wanji S Exp Parasitol; 2021 Oct; 229():108143. PubMed ID: 34437906 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle. Renz A; Trees AJ; Achu-Kwi D; Edwards G; Wahl G Trop Med Parasitol; 1995 Mar; 46(1):31-7. PubMed ID: 7631125 [TBL] [Abstract][Full Text] [Related]
13. Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle. Boussinesq M; Enyong P; Chounna-Ndongmo P; Njouendou AJ; Pion SD; Rech A; Roberge C; Gaudriault G; Wanji S Parasite; 2020; 27():36. PubMed ID: 32420864 [TBL] [Abstract][Full Text] [Related]
14. Onchocerca ochengi acquisition in zebu Gudali cattle exposed to natural transmission: parasite population dynamics and IgG antibody subclass responses to Ov10/Ov11 recombinant antigens. Achukwi MD; Harnett W; Bradley J; Renz A Vet Parasitol; 2004 Jun; 122(1):35-49. PubMed ID: 15158555 [TBL] [Abstract][Full Text] [Related]
15. Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi. Townson S; Hutton D; Siemienska J; Hollick L; Scanlon T; Tagboto SK; Taylor MJ Ann Trop Med Parasitol; 2000 Dec; 94(8):801-16. PubMed ID: 11214099 [TBL] [Abstract][Full Text] [Related]
16. Effects of an Onchocerca-derived cysteine protease inhibitor on microfilariae in their simuliid vector. Kläger SL; Hagen HE; Bradley JE Parasitology; 1999 Mar; 118 ( Pt 3)():305-10. PubMed ID: 10205807 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens. Mbah GE; Ayiseh RB; Cho-Ngwa F BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037 [TBL] [Abstract][Full Text] [Related]
18. Galectins from Onchocerca ochengi and O. volvulus and their immune recognition by Wistar rats, Gudali zebu cattle and human hosts. Ngwasiri NN; Brattig NW; Ndjonka D; Liebau E; Paguem A; Leusder D; Kingsley MT; Eisenbarth A; Renz A; Daniel AM BMC Microbiol; 2021 Jan; 21(1):5. PubMed ID: 33407120 [TBL] [Abstract][Full Text] [Related]
19. Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure. Makepeace BL; Jensen SA; Laney SJ; Nfon CK; Njongmeta LM; Tanya VN; Williams SA; Bianco AE; Trees AJ PLoS Negl Trop Dis; 2009 Nov; 3(11):e544. PubMed ID: 19901988 [TBL] [Abstract][Full Text] [Related]
20. Emodepside targets SLO-1 channels of Onchocerca ochengi and induces broad anthelmintic effects in a bovine model of onchocerciasis. Bah GS; Schneckener S; Hahnel SR; Bayang NH; Fieseler H; Schmuck GM; Krebber R; Sarr A; Terjung C; Ngangyung HF; Ekale DD; Mfopit YM; Rufener L; Graham-Brown J; Tanya VN; Glenschek-Sieberth M; Kulke D; Makepeace BL PLoS Pathog; 2021 Jun; 17(6):e1009601. PubMed ID: 34077488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]